{"schema_version":"1.0","canonical_url":"https://patentable.app/patents/US-11982672","patent":{"patent_number":"US-11982672","title":"Methods","assignee":null,"inventors":[],"filing_date":"2022-06-03T00:00:00.000Z","publication_date":"2024-05-14T00:00:00.000Z","cpc_codes":["G01N","G01N","C12Q","G16H","C12Q"],"num_claims":8,"abstract":"The present invention relates to a chimeric antigen receptor (CAR) which comprises an antigen-binding domain which selectively binds TCR beta constant region 1 (TRBC1) or TRBC2; cells; such a T cells comprising such a CAR; and the use of such cells for the treatment of a T-cell lymphoma or leukaemia in a subject."},"analysis":{"summary":null,"layman_explanation":null,"technical_analysis":null,"business_analysis":null,"faqs":null,"topics":[],"tech_cluster":null},"seo":{"title":"Methods","description":"The present invention relates to a chimeric antigen receptor (CAR) which comprises an antigen-binding domain which selectively binds TCR beta constant region 1 (TRBC1) or TRBC2; cells; such a T cells ","keywords":[]},"attribution":{"source":"Patentable","source_url":"https://patentable.app","canonical_url":"https://patentable.app/patents/US-11982672","license":"CC-BY-4.0-like","license_terms":"AI-generated analysis on this page (summary, layman_explanation, technical_analysis, business_analysis, faqs) may be reused with attribution and a visible link back to the canonical URL above. Patent abstracts, claims, and bibliographic data are USPTO public domain.","required_link":"https://patentable.app/patents/US-11982672","citation_suggestion":"Patentable. \"Methods\" (US-11982672). https://patentable.app/patents/US-11982672","copyright_holder":"Nomic Interactive Technology LLC"},"links":{"html":"https://patentable.app/patents/US-11982672","json":"https://patentable.app/api/llm-context/US-11982672","site":"https://patentable.app","llms_txt":"https://patentable.app/llms.txt"},"generated_at":"2026-05-31T17:59:16.820Z"}